SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses Elon Musk's recent $1 billion stock purchase, viewed by some as a sign of confidence and a potential catalyst for further gains. Community members are debating whether this move signals long-term potential or is simply a pump, while also weighing factors like upcoming FSD releases and potential impacts from the Fed. Some traders point to technical indicators and potential resistance levels, while others express concerns about valuation and broader market conditions.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid growing interest in AI-driven security solutions and biometric software deployments, particularly following news of a congresswoman purchasing shares. The community is actively discussing potential government contracts, short squeeze opportunities, and comparisons to $PLTR, with bullish investors pointing to favorable chart setups and anticipating significant gains. Sentiment suggests building confidence in BBAI's long-term potential within the AI and defense sectors.

Slopana

Slopana is trending as community members rally around its meme-driven identity on the Solana blockchain. Conversations highlight its availability on Phantom Wallet and anticipation for potential gains, with some suggesting it could become a leading meme coin. The coin's connection to Solana, with some calling it the chain's mascot, is also fueling interest.

Aventus

Aventus ($AVT.X) is trending amid community discussion about its low market cap, recent partnerships, and potential for significant gains, with some drawing comparisons to other low-supply tokens.  Excitement is building around its technology and real-world applications, including partnerships with Vodafone and Heathrow Airport. Traders are closely watching volume and price action, speculating on a potential breakout.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the market reaches new all-time highs, fueling discussions about a potential rate cut and its implications. Community members are actively debating whether the expected rate cut is already priced in and if a "sell the news" event is on the horizon. Some traders express concerns about overbought conditions and the potential for a significant pullback, while others remain bullish, citing positive economic data and ongoing momentum.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as community members discuss potential bear traps and await possible rate cuts, anticipating a shift in market dynamics. Conversation highlights a focus on accumulating related tokens like $SLOPANA.X and $QOOMER.X, primarily through Phantom Wallet. Some traders believe BTC will test higher levels by the end of the year.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics ($CVKD) is trending as traders discuss its potential for a significant move, fueled by its enhanced anticoagulation pipeline. Community members are closely watching for a breakout above resistance, anticipating a bullish run if volume increases. Recent news highlights the company's pipeline expansion and portfolio acquisition, further contributing to the positive sentiment.

Definitive is an onchain trading platform democratizing advanced trading tools for the masses. Trade any token on any chain with advanced trade order types including Market, Limit Buy/Sell, Stop Loss and TWAP orders.  Route your trade instantly across 100+ DEXs and liquidity pools to get the best prices on every trade. Definitive is built by former Coinbase Institutional trading alumni and active DeFi experts.

Definitive

Definitive's EDGE.X is trending as community members discuss its potential for significant gains, drawing comparisons to AERO's early success and highlighting its strong performance amidst broader market fluctuations. Speculation around a potential Binance listing and the project's unique features, like its DEX platform and cross-chain capabilities, are fueling bullish sentiment, with many anticipating a move towards dollar land.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending as investors speculate about a potential buyout, fueled by trial updates and key personnel moves, including the former CMO joining Bayer's Vividion. The community discusses potential acquirers like Roche and Bayer, buyout price predictions, and the impact of the company's strategic review process. Bullish investors are focused on the company's promising pipeline and are holding firm.

Allbirds, Inc. is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. It offers Men's Shoes, Women's Shoes, Men's Apparel, Women's Apparel, Socks, and Gift Cards. The company was founded by Timothy Brown and Joseph Zev Zwillinger on May 6, 2015 and is headquartered in San Francisco, CA.

Allbirds Inc - Ordinary Shares Class A

Allbirds ($BIRD) is trending amid mixed sentiment, with some traders hoping for a short squeeze while others express concerns about the company's losses and brand relevance. Community members are debating the potential for a turnaround, recent insider selling, and discussing a possible buyout. Overall, the stock's future appears uncertain as the footwear company navigates challenges in a competitive market.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -44.75% and +14.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of -20.93% and -25.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -104.20% and +14.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates

Relay Therapeutics (RLAY) delivered earnings and revenue surprises of +16.33% and +35.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates

Madrigal (MDGL) delivered earnings and revenue surprises of +45.40% and +32.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates

Buy Rating Affirmed for Profound Medical on Reimbursement and Market Expansion Prospects

In a report released today, Rick Wise from Stifel Nicolaus upgraded Profound Medical (PRN Research Report) to a Buy, with a price target of $12.0...

Profound Medical (PROF, $8.27) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that PROF's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Profound Medical (PROF, $8.27) price exceeded its 50-day Moving Average on April 01, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

Profound Medical (NASDAQ:PROF) and Minerva Surgical (NASDAQ:UTRS) Head to Head Survey

Profound Medical (NASDAQ:PROF - Get Free Report) and Minerva Surgical (NASDAQ:UTRS - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the...

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Profound Medical Corp

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

PROF
Profound Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PROF News

PROF Profound Medical Corp